Methyl Palmitate – A suitable adjuvant for Sorafenib...

  • Main
  • 2020 / 10
  • Methyl Palmitate – A suitable adjuvant for Sorafenib...
Basic & Clinical Pharmacology & Toxicology 2020 / 10

Methyl Palmitate – A suitable adjuvant for Sorafenib therapy to reduce in vivo toxicity and to enhance anti‐cancer effects on Hepatocellular Carcinoma Cells

Breeta, R Evangeline, Grace, V.M. Berlin, Wilson, D. David
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Basic & Clinical Pharmacology & Toxicology
DOI:
10.1111/bcpt.13525
Date:
October, 2020
File:
PDF, 929 KB
2020
Conversion to is in progress
Conversion to is failed